November 7, 2007 NASD OTC-BB: MRDAF (MARKET WIRE)

LipoLaser Global Distribution Footprint Widens to Include Mexico

Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of advanced medical equipment, is pleased to announce that its North American distributor, Belgium Medical Inc. has signed a distribution subcontract with World Scientific Instrument (WSIM) for the marketing and sales of Meridian's LipoLaser in Mexico.

The contract stipulates that WSIM will be granted an exclusive license to market the LipoLaser throughout the Western States of Mexico including Baja California North and South, Sonora, Sinaloa, Nayarit and Jalisco. WSIM has sold high-quality medical equipment for four years and established more than 3,000 customer accounts nationwide.

The LipoLaser will join over 100 other medical-grade devices currently available from WSIM including ultrasound, radiology, CT as well as diagnostic equipment and furniture required for standard hospital treatment, emergency treatment, surgery and recovery. For WSIM, the LipoLaser presents an opportunity to expand their business into the rapidly growing aesthetics industry.

"Our partnership with Meridian for LipoLaser distribution will allow us to meet the increasing demand among our existing customers for non-surgical alternatives for inch loss and spot fat reduction," said Fernando Sanchex Soto, WSIM President and General Manager. "Based on a successful sales and marketing model for the Western States, we have plans to expand distribution of LipoLaser to include Mexico City and eventually the entire nation."

For more information about WSIM, please visit their website www.wsim.com.mx.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA clearance and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: https://MeridianMedical.ca